These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines? Ho NI; Huis In 't Veld LGM; Raaijmakers TK; Adema GJ Front Immunol; 2018; 9():2874. PubMed ID: 30619259 [TBL] [Abstract][Full Text] [Related]
8. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens. Neuenhahn M; Busch DH Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665 [TBL] [Abstract][Full Text] [Related]
9. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset. Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900 [TBL] [Abstract][Full Text] [Related]
10. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming. Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457 [TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8 Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032 [TBL] [Abstract][Full Text] [Related]
12. Engineering anti-cancer nanovaccine based on antigen cross-presentation. Warrier VU; Makandar AI; Garg M; Sethi G; Kant R; Pal JK; Yuba E; Gupta RK Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652460 [TBL] [Abstract][Full Text] [Related]
13. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization. Sudowe S; Dominitzki S; Montermann E; Bros M; Grabbe S; Reske-Kunz AB Immunology; 2009 Sep; 128(1 Suppl):e193-205. PubMed ID: 18800984 [TBL] [Abstract][Full Text] [Related]
14. Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines. Zachova K; Krupka M; Raska M Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):1-18. PubMed ID: 26518489 [TBL] [Abstract][Full Text] [Related]
15. If it ain't broke, break it: facilitating antigen cross-presentation. Rodríguez-Silvestre P; Kozik P Trends Mol Med; 2022 Apr; 28(4):251-252. PubMed ID: 35288004 [TBL] [Abstract][Full Text] [Related]
16. Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. Gasteiger G; Kastenmuller W; Ljapoci R; Sutter G; Drexler I J Virol; 2007 Nov; 81(21):11925-36. PubMed ID: 17699574 [TBL] [Abstract][Full Text] [Related]
18. Effective Priming of Herpes Simplex Virus-Specific CD8 Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130 [TBL] [Abstract][Full Text] [Related]
19. Impaired cross-presentation of CD8α+ CD11c+ dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner. Aleyas AG; Han YW; Patil AM; Kim SB; Kim K; Eo SK Eur J Immunol; 2012 Oct; 42(10):2655-66. PubMed ID: 22706912 [TBL] [Abstract][Full Text] [Related]
20. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node. Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]